CIK: 0001750183 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value ($000): $490 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CURR | CURRENC GROUP INC | 263,200 | $442 | 90.2% | $0.99 | +71.6% | CL A ORD SHS | G47862100 |
| — | ASPIRE BIOPHARMA HLDGS INC | 202,897 | $42 | 8.5% | $0.21 | — | COM | 738920107 |
| ASBPW | ASPIRE BIOPHARMA HLDGS INC | 207,693 | $6 | 1.3% | $0.03 | — | *W EXP 02/14/203 | 738920115 |